159 related articles for article (PubMed ID: 2106141)
1. Pituitary mammosomatotroph adenomas develop in old mice transgenic for growth hormone-releasing hormone.
Asa SL; Kovacs K; Stefaneanu L; Horvath E; Billestrup N; Gonzalez-Manchon C; Vale W
Proc Soc Exp Biol Med; 1990 Mar; 193(3):232-5. PubMed ID: 2106141
[TBL] [Abstract][Full Text] [Related]
2. The role of hypothalamic hormones in the pathogenesis of pituitary adenomas.
Asa SL
Pathol Res Pract; 1991 Jun; 187(5):581-3. PubMed ID: 1923953
[TBL] [Abstract][Full Text] [Related]
3. Pituitary adenomas in mice transgenic for growth hormone-releasing hormone.
Asa SL; Kovacs K; Stefaneanu L; Horvath E; Billestrup N; Gonzalez-Manchon C; Vale W
Endocrinology; 1992 Nov; 131(5):2083-9. PubMed ID: 1425411
[TBL] [Abstract][Full Text] [Related]
4. Morphologic effects of hGRH gene expression on the pituitary, liver, and pancreas of MT-hGRH transgenic mice. An in situ hybridization analysis.
Lloyd RV; Jin L; Chang A; Kulig E; Camper SA; Ross BD; Downs TR; Frohman LA
Am J Pathol; 1992 Oct; 141(4):895-906. PubMed ID: 1415483
[TBL] [Abstract][Full Text] [Related]
5. Adenohypophysial changes in mice transgenic for human growth hormone-releasing factor: a histological, immunocytochemical, and electron microscopic investigation.
Stefaneanu L; Kovacs K; Horvath E; Asa SL; Losinski NE; Billestrup N; Price J; Vale W
Endocrinology; 1989 Nov; 125(5):2710-8. PubMed ID: 2507296
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical characterization of "hyperplasia-adenoma sequence" in the pituitaries of transgenic mice expressing a human growth hormone-releasing factor gene.
Umemura S; Oda K; Utsunomiya H; Sanno N; Itoh J; Katakami H; Osamura RY
Tokai J Exp Clin Med; 1995 Jul; 20(2):71-9. PubMed ID: 8797263
[TBL] [Abstract][Full Text] [Related]
7. Mammosomatotroph adenoma cells secrete both growth hormone and prolactin.
Kojima Y; Arita J; Kuwana N
Neurol Med Chir (Tokyo); 1995 Nov; 35(11):791-6. PubMed ID: 8657329
[TBL] [Abstract][Full Text] [Related]
8. The effect of GHRH on somatotrope hyperplasia and tumor formation in the presence and absence of GH signaling.
Kineman RD; Teixeira LT; Amargo GV; Coschigano KT; Kopchick JJ; Frohman LA
Endocrinology; 2001 Sep; 142(9):3764-73. PubMed ID: 11517152
[TBL] [Abstract][Full Text] [Related]
9. Targeted overexpression of luteinizing hormone causes ovary-dependent functional adenomas restricted to cells of the Pit-1 lineage.
Mohammad HP; Abbud RA; Parlow AF; Lewin JS; Nilson JH
Endocrinology; 2003 Oct; 144(10):4626-36. PubMed ID: 12960102
[TBL] [Abstract][Full Text] [Related]
10. Congenital gigantism due to growth hormone-releasing hormone excess and pituitary hyperplasia with adenomatous transformation.
Zimmerman D; Young WF; Ebersold MJ; Scheithauer BW; Kovacs K; Horvath E; Whitaker MD; Eberhardt NL; Downs TR; Frohman LA
J Clin Endocrinol Metab; 1993 Jan; 76(1):216-22. PubMed ID: 8421089
[TBL] [Abstract][Full Text] [Related]
11. [Morphology of pituitary neoplasms].
Sasano N; Andoh N; Ikeda H
Nihon Rinsho; 1986 Mar; 44(3):645-50. PubMed ID: 3525897
[No Abstract] [Full Text] [Related]
12. Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia in dopamine D2 receptor-deficient mice.
Asa SL; Kelly MA; Grandy DK; Low MJ
Endocrinology; 1999 Nov; 140(11):5348-55. PubMed ID: 10537166
[TBL] [Abstract][Full Text] [Related]
13. Galanin gene expression is increased in the anterior pituitary gland of the human growth hormone-releasing hormone transgenic mouse.
Moore JP; Morrison DG; Hyde JF
Endocrinology; 1994 May; 134(5):2005-10. PubMed ID: 7512494
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone-releasing hormone and pituitary development, hyperplasia and tumorigenesis.
Frohman LA; Kineman RD
Trends Endocrinol Metab; 2002 Sep; 13(7):299-303. PubMed ID: 12163232
[TBL] [Abstract][Full Text] [Related]
15. Reversible transdifferentiation: interconversion of somatotrophs and lactotrophs in pituitary hyperplasia.
Vidal S; Horvath E; Kovacs K; Lloyd RV; Smyth HS
Mod Pathol; 2001 Jan; 14(1):20-8. PubMed ID: 11211306
[TBL] [Abstract][Full Text] [Related]
16. Use of the metallothionein promoter-human growth hormone-releasing hormone (GHRH) mouse to identify regulatory pathways that suppress pituitary somatotrope hyperplasia and adenoma formation due to GHRH-receptor hyperactivation.
Luque RM; Soares BS; Peng XD; Krishnan S; Cordoba-Chacon J; Frohman LA; Kineman RD
Endocrinology; 2009 Jul; 150(7):3177-85. PubMed ID: 19342460
[TBL] [Abstract][Full Text] [Related]
17. The role of hormones, growth factors and their receptors in pituitary tumorigenesis.
Ezzat S
Brain Pathol; 2001 Jul; 11(3):356-70. PubMed ID: 11414477
[TBL] [Abstract][Full Text] [Related]
18. Effects of estrogen and dexamethasone on a transgenic pituitary cell line. Regulation of hormone and chromogranin/secretogranin expression.
Thiny MT; Antczak C; Fields K; Jin L; Lloyd RV
Lab Invest; 1994 Jun; 70(6):899-906. PubMed ID: 7912292
[TBL] [Abstract][Full Text] [Related]
19. Light and electron microscopic observation of the same mammosomatotroph cell in a mixed growth hormone- and prolactin-secreting pituitary adenoma--case report.
Kabuto M; Kubota T; Kobayashi H; Nakagawa T
Neurol Med Chir (Tokyo); 1993 Apr; 33(4):238-41. PubMed ID: 7685856
[TBL] [Abstract][Full Text] [Related]
20. A growth hormone-releasing hormone-producing pancreatic islet cell tumor metastasized to the pituitary is associated with pituitary somatotroph hyperplasia and acromegaly.
Sanno N; Teramoto A; Osamura RY; Genka S; Katakami H; Jin L; Lloyd RV; Kovacs K
J Clin Endocrinol Metab; 1997 Aug; 82(8):2731-7. PubMed ID: 9253362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
